Antipsychotic drugs for anorexia nervosa.

IF 8.8 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Cochrane Database of Systematic Reviews Pub Date : 2024-11-06 DOI:10.1002/14651858.CD014834

Kazufumi Yoshida, Hissei Imai, Ethan Sahker, Yan Luo, Shino Kikuchi, Yasushi Tsujimoto, Ioannis Michopoulos, Toshi A Furukawa, Norio Watanabe

引用次数: 0

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of antipsychotic drugs (both first- and second-generation antipsychotics) compared to placebo on body weight gain, psychological symptoms, acceptability, and adverse events for people with anorexia nervosa.

查看原文本刊更多论文

治疗神经性厌食症的抗精神病药物。

目标：这是一份科克伦综述（干预）协议。目标如下评估抗精神病药物（包括第一代和第二代抗精神病药物）与安慰剂相比，对神经性厌食症患者体重增加、心理症状、可接受性和不良事件的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cochrane Database of Systematic Reviews 医学-医学：内科

CiteScore

10.60

自引率

2.40%

发文量

173

审稿时长

1-2 weeks

期刊介绍： The Cochrane Database of Systematic Reviews (CDSR) stands as the premier database for systematic reviews in healthcare. It comprises Cochrane Reviews, along with protocols for these reviews, editorials, and supplements. Owned and operated by Cochrane, a worldwide independent network of healthcare stakeholders, the CDSR (ISSN 1469-493X) encompasses a broad spectrum of health-related topics, including health services.